TECX
Tectonic Therapeutic, Inc.Company Information
- Company Name
- Tectonic Therapeutic, Inc.
- CIK
- CIK0001681087
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- TECX: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2836
- SIC Description
- Biological Products, (No Diagnostic Substances)
- Ticker
- TECX
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-02-11
- Last sale
- 2026-08-25
- Shares purchased (TTM)
- 8,500
- Shares sold (TTM)
- 20,235
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 13,592,971
- Shares outstanding
- 18,964,008
- Ownership
- 71.68%
Earnings Market Reaction
- Filing date
- 2026-08-06
- Price on filing date
- —
- 1-month reaction
- 17.87%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 227 | 237 | 254 | 268 | 287 | 306 | 141 | 159 | 185 | 19 | 29 | 6 | ||||||
| Prepaid Expense And Other Assets Current | 4 | 3 | 3 | 4 | 3 | 3 | 6 | 4 | 2 | 1 | 2 | 3 | ||||||
| Assets Held For Sale Not Part Of Disposal Group Current | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Restricted Cash Current | 0 | 0 | 1 | 1 | - | - | 0 | - | - | 0 | 0 | 0 | ||||||
| Assets Current | 231 | 240 | 257 | 273 | 291 | 310 | 147 | 163 | 187 | 92 | 31 | 109 | ||||||
| Property Plant And Equipment Net | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 3 | 3 | - | 3 | 0 | ||||||
| Finance Lease Right Of Use Asset | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 2 | - | 1 | - | ||||||
| Deferred Costs | - | - | - | - | - | - | 0 | 0 | 0 | - | 1 | - | ||||||
| Operating Lease Right Of Use Asset | 4 | 4 | 1 | 1 | 1 | 2 | 2 | 2 | 1 | 0 | 3 | 1 | ||||||
| Restricted Cash Noncurrent | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | ||||||
| Other Assets Noncurrent | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | ||||||
| Assets | 237 | 247 | 261 | 277 | 295 | 315 | 153 | 169 | 194 | 92 | 39 | 111 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 2 | 3 | 1 | 1 | 3 | 6 | 1 | 3 | 4 | 0 | 0 | 1 | ||||||
| Accrued Liabilities Current | 7 | 9 | 7 | 7 | 7 | 5 | 8 | 13 | 20 | 3 | 8 | 5 | ||||||
| Long Term Notes Payable | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Finance Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | - | ||||||
| Operating Lease Liability Current | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 0 | 1 | 2 | ||||||
| Liabilities Current | 10 | 13 | 10 | 9 | 11 | 14 | 12 | 17 | 26 | 4 | 41 | 8 | ||||||
| Operating Lease Liability Noncurrent | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | - | 2 | 0 | ||||||
| Finance Lease Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | - | 1 | - | ||||||
| Liabilities | 13 | 16 | 10 | 9 | 12 | 14 | 12 | 18 | 28 | 4 | 43 | 8 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | - | - | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | - | ||||||
| Temporary Equity Carrying Amount Attributable To Parent | - | - | - | - | - | - | 0 | 0 | 0 | - | 81 | - | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 494 | 478 | 474 | 471 | 468 | 466 | 289 | 287 | 285 | 573 | 6 | 571 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 0 | 0 | -0 | -0 | -0 | 0 | 0 | -0 | -0 | - | -0 | - | ||||||
| Retained Earnings Accumulated Deficit | -270 | -248 | -223 | -204 | -184 | -164 | -149 | -136 | -118 | -484 | -91 | -468 | ||||||
| Stockholders Equity | 224 | 230 | 251 | 268 | 284 | 301 | 141 | 150 | 166 | -100 | -85 | -80 | ||||||
| Liabilities And Stockholders Equity | 237 | 247 | 261 | 277 | 295 | 315 | 153 | 169 | 194 | 92 | 39 | 111 | ||||||
| Preferred Stock Shares Authorized | - | - | 10 | 10 | 10 | 10 | 10 | 10 | - | 10 | 0 | - | ||||||
| Preferred Stock Par Or Stated Value Per Share | - | - | 0.00 | - | - | - | 0.00 | - | - | 0.00 | 0.00 | - | ||||||
| Preferred Stock Shares Issued | - | - | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | - | ||||||
| Preferred Stock Shares Outstanding | - | - | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | ||||||
| Common Stock Shares Issued | 19 | 19 | 19 | 19 | 19 | 19 | 15 | 15 | 15 | 45 | 1 | 45 | ||||||
| Shares Outstanding | 19 | 19 | 19 | 19 | 19 | 19 | 15 | 15 | 15 | 45 | 1 | 45 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialTectonic Therapeutic, Inc. (TECX) — SEC Financial Statements & Analysis
Tectonic Therapeutic, Inc. (TECX) is a biological products, (no diagnostic substances) company, incorporated in NY. Tectonic Therapeutic, Inc. trades on Nasdaq as: TECX. Tectonic Therapeutic, Inc. (TECX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06. Based on that filing, Tectonic Therapeutic, Inc. carries a market cap of $651.98M, a P/E ratio of -7.60x, a P/B ratio of 2.91x, an enterprise value of $424.62M, and an EV/EBITDA multiple of -4.53x. On profitability, it posts a Return on Equity (ROE) of -33.80% and a Return on Assets (ROA) of -32.23%. Per share, it reports EPS of $-4.52, diluted EPS of $-4.52, free cash flow per share of $-3.82, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of 30.02% year-over-year and EPS growth of 28.07% year-over-year. On the balance sheet, it maintains a current ratio of 22.29x, a quick ratio of 21.90x, working capital of $220.73M, a debt-to-equity ratio of 0.06x, a debt ratio of 0.06, an interest coverage ratio of -2373.13x, free cash flow of $-72.42M (TTM), and net debt of $-227.37M. Figures sourced from SEC EDGAR.
- Market Cap
- $651.98M
- P/E TTM
- -7.60x
- EPS TTM
- $-4.52
- P/B TTM
- 2.91x
- ROE TTM
- -33.80%
- ROA TTM
- -32.23%
- Debt To Equity
- 0.06x
- Free Cash Flow TTM
- $-72.42M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Tectonic Therapeutic, Inc. in?
Tectonic Therapeutic, Inc. (TECX) operates in the Biological Products, (No Diagnostic Substances) industry.
What exchange does TECX trade on?
Tectonic Therapeutic, Inc. (TECX) trades on the Nasdaq.
Where is Tectonic Therapeutic, Inc. incorporated?
Tectonic Therapeutic, Inc. is incorporated in NY.
When was Tectonic Therapeutic, Inc. (TECX)'s most recent SEC filing?
Tectonic Therapeutic, Inc. (TECX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06.
What is TECX's market cap?
Tectonic Therapeutic, Inc. (TECX) has a market capitalization of $651.98M as of 2026-06-30.
What is TECX's EPS (earnings per share)?
Tectonic Therapeutic, Inc. (TECX)'s trailing twelve month EPS is $-4.52 as of 2026-06-30.
What is TECX's ROE (return on equity)?
Tectonic Therapeutic, Inc. (TECX)'s trailing twelve month Return on Equity (ROE) is -33.80% as of 2026-06-30.
What is TECX's ROA (return on assets)?
Tectonic Therapeutic, Inc. (TECX)'s trailing twelve month Return on Assets (ROA) is -32.23% as of 2026-06-30.
What is TECX's EV/EBITDA?
Tectonic Therapeutic, Inc. (TECX)'s trailing twelve month EV/EBITDA is -4.53x as of 2026-06-30.